Correlation
The correlation between VNDA and PLTR is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
VNDA vs. PLTR
Compare and contrast key facts about Vanda Pharmaceuticals Inc. (VNDA) and Palantir Technologies Inc. (PLTR).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: VNDA or PLTR.
Performance
VNDA vs. PLTR - Performance Comparison
Loading data...
Key characteristics
VNDA:
-0.28
PLTR:
7.09
VNDA:
-0.09
PLTR:
5.33
VNDA:
0.99
PLTR:
1.72
VNDA:
-0.15
PLTR:
11.36
VNDA:
-0.50
PLTR:
39.09
VNDA:
25.64%
PLTR:
13.46%
VNDA:
48.38%
PLTR:
72.56%
VNDA:
-98.42%
PLTR:
-84.62%
VNDA:
-86.30%
PLTR:
0.00%
Fundamentals
VNDA:
$258.72M
PLTR:
$298.21B
VNDA:
-$0.75
PLTR:
$0.25
VNDA:
-2.42
PLTR:
3.87
VNDA:
1.28
PLTR:
95.73
VNDA:
0.51
PLTR:
53.22
VNDA:
$201.35M
PLTR:
$3.12B
VNDA:
$186.45M
PLTR:
$2.49B
VNDA:
-$66.55M
PLTR:
$428.72M
Returns By Period
In the year-to-date period, VNDA achieves a -9.39% return, which is significantly lower than PLTR's 74.24% return.
VNDA
-9.39%
-2.25%
-15.73%
-15.07%
-23.85%
-18.02%
-9.23%
PLTR
74.24%
13.41%
96.45%
507.84%
147.61%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
VNDA vs. PLTR — Risk-Adjusted Performance Rank
VNDA
PLTR
VNDA vs. PLTR - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Vanda Pharmaceuticals Inc. (VNDA) and Palantir Technologies Inc. (PLTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
VNDA vs. PLTR - Dividend Comparison
Neither VNDA nor PLTR has paid dividends to shareholders.
Drawdowns
VNDA vs. PLTR - Drawdown Comparison
The maximum VNDA drawdown since its inception was -98.42%, which is greater than PLTR's maximum drawdown of -84.62%. Use the drawdown chart below to compare losses from any high point for VNDA and PLTR.
Loading data...
Volatility
VNDA vs. PLTR - Volatility Comparison
The current volatility for Vanda Pharmaceuticals Inc. (VNDA) is 13.52%, while Palantir Technologies Inc. (PLTR) has a volatility of 21.03%. This indicates that VNDA experiences smaller price fluctuations and is considered to be less risky than PLTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
VNDA vs. PLTR - Financials Comparison
This section allows you to compare key financial metrics between Vanda Pharmaceuticals Inc. and Palantir Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VNDA vs. PLTR - Profitability Comparison
VNDA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Vanda Pharmaceuticals Inc. reported a gross profit of 46.52M and revenue of 50.04M. Therefore, the gross margin over that period was 93.0%.
PLTR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Palantir Technologies Inc. reported a gross profit of 710.89M and revenue of 883.86M. Therefore, the gross margin over that period was 80.4%.
VNDA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Vanda Pharmaceuticals Inc. reported an operating income of -41.03M and revenue of 50.04M, resulting in an operating margin of -82.0%.
PLTR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Palantir Technologies Inc. reported an operating income of 176.05M and revenue of 883.86M, resulting in an operating margin of 19.9%.
VNDA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Vanda Pharmaceuticals Inc. reported a net income of -29.49M and revenue of 50.04M, resulting in a net margin of -58.9%.
PLTR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Palantir Technologies Inc. reported a net income of 214.03M and revenue of 883.86M, resulting in a net margin of 24.2%.